|
Of Counsel to the law firm Jones Day, and a Co-Director of Education Programs at Stanford University School of Law, Mr. Koppes is a member of the Board of Directors of Valeant Pharmaceuticals International (formerly ICN Pharmaceuticals, Inc.) and serves on that Board's Corporate Governance, Nominating and Compliance Committees. He also serves on the Board of Directors of the Investor Responsibility Research Center (IRRC) located in Washington, D.C. and the International Corporate Governance Network (ICGN) located in London. Mr. Koppes has been on Apria's Board since 1998. | 